CervoMed Inc. Revenue, Net (Deprecated 2018-01-31)
CervoMed Inc. (CRVO) reported Revenue, Net (Deprecated 2018-01-31) of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2014-05-20
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $71.67K, a 50.00% decline year-over-year.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for fiscal 2013 was $71.67K, a 80.87% decline from fiscal 2012.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for fiscal 2012 was $374.54K, a 34.35% decline from fiscal 2011.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for fiscal 2011 was $570.48K, a 1319.48% increase from fiscal 2010.
- CervoMed Inc. revenue, net (deprecated 2018-01-31) for fiscal 2010 was $40.19K.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-20 | $0.00 derived: sum of 2 quarters · filed 2014-05-20 | $0.00 derived: sum of 3 quarters · filed 2014-05-20 | $71.67K derived: sum of 4 quarters · filed 2014-05-20 | |
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2014-04-23 | $71.67K derived: sum of 3 quarters · filed 2014-04-23 | $71.67K 10-K/A · filed 2014-04-23 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | $71.67K derived: sum of 2 quarters · filed 2013-11-19 | $71.67K 10-Q · filed 2013-11-19 | $71.67K derived: sum of 4 quarters · filed 2014-05-20 | |
| 2013-06-30 | $71.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $71.67K 10-Q · filed 2013-08-14 | $71.67K derived: sum of 3 quarters · filed 2014-05-20 | $215.00K derived: sum of 4 quarters · filed 2014-05-20 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-20 | $71.67K 10-Q/A · filed 2013-05-20 | $0.00 derived: sum of 2 quarters · filed 2014-05-20 | $143.33K derived: sum of 3 quarters · filed 2014-05-20 | $286.67K derived: sum of 4 quarters · filed 2014-05-20 |
| 2012-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $143.33K derived: sum of 2 quarters · filed 2014-04-23 | $286.67K derived: sum of 3 quarters · filed 2014-04-23 | $374.54K 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $143.33K 10-Q · filed 2012-11-19 | $286.67K derived: sum of 2 quarters · filed 2013-11-19 | $374.54K 10-Q · filed 2013-11-19 | $766.49K derived: sum of 4 quarters · filed 2013-11-19 | |
| 2012-06-30 | $143.33K 10-Q · filed 2013-11-19 | $71.67K 10-Q/A · filed 2012-09-07 | $231.21K 10-Q · filed 2013-08-14 | $623.15K derived: sum of 3 quarters · filed 2013-11-19 | $873.35K derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-03-31 | $159.54K 10-Q/A · filed 2013-05-20 | $479.82K derived: sum of 2 quarters · filed 2013-05-20 | $730.02K derived: sum of 3 quarters · filed 2013-05-20 | $730.02K derived: sum of 4 quarters · filed 2013-05-20 | |
| 2011-12-31 | $320.27K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | $570.48K derived: sum of 2 quarters · filed 2012-11-19 | $570.48K derived: sum of 3 quarters · filed 2012-11-19 | $570.48K 10-K · filed 2012-05-21 | |
| 2011-09-30 | $250.20K 10-Q · filed 2012-11-19 | $250.20K derived: sum of 2 quarters · filed 2012-11-19 | $250.20K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-16 | $0.00 10-Q · filed 2011-08-16 | |||
| 2010-12-31 | $40.19K 10-K · filed 2012-05-21 | ||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-16 | $0.00 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |